European stocks lose strength but optimism continues to reign
The European stock markets have continued to register gains for another day, still driven by the advances of the Covid-19 vaccine announced by Pfizer together with BioNtech at the beginning of the week. However, the rises are much more moderate as none of the main indices have exceeded a 0.5% rise.
Today, in addition, several companies have presented results, such as Mediaset, the Italian television group, which rose more than 7% in the stock market after increasing its advertising revenue despite the coronavirus pandemic. In Germany, E.On has reported a drop in its earnings in the third quarter, but has confirmed its outlook for the year as a whole due to the recovery of the market, so its shares are up almost 1%.
The exception is ABN AMRO, whose shares fell more than 3% due to results that haven't convinced investors, despite being better than expected.
Source: Admiral Markets MetaTrader 5. ABN AMRO CFD Daily Chart. Data range: from November 19, 2015, to November 11, 2020. Prepared on November 11, 2020, at 11:30 am. Please note that past performance does not guarantee future returns.
On the other hand, apart from the vaccine and corporate results, the market is also awaiting intervention from the president of the European Central Bank (ECB), Christine Lagarde, at 2:00 p.m. CET.
Did you know that with Admiral Markets UK Ltd you can invest in CFDs on ABN AMRO shares? Just open a demo trading account or a live account, choose the ABN AMRO symbol in your MetaTrader and start trading! Click on the following banner for more information:
INFORMATION ON ANALYTICAL MATERIALS:
The data provided provides additional information on all analyzes, estimates, forecasts, forecasts, market reviews, weekly outlooks or other evaluations or similar information (hereinafter "Analysis") published on the Admiral Markets website. Before making any investment decisions, pay close attention to the following:
1. This is a marketing communication. The content is posted for informational purposes only and should not be construed as investment advice or recommendation. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and is not subject to any prohibition on pre-dissemination of investment research.
2. Each investment decision is made by each client alone, while Admiral Markets UK Ltd (Admiral Markets) will not be liable for any loss or damage arising from such a decision, whether based on content or not.
3. In order to protect the interests of our clients and the objectivity of the Analysis, Admiral Markets has established relevant internal procedures for the prevention and management of conflicts of interest.
4. The analysis is prepared by an independent analyst, Carolina Caro, SEO implementer (hereinafter "Author") based on personal estimates.
5. While all reasonable efforts are made to ensure that all sources of content are reliable and that all information is presented, as much as possible, in an understandable, timely, accurate, and complete manner, Admiral Markets does not guarantee accuracy. or integrity of any information contained in the Analysis.
6. Any past performance or modelling of the financial instruments indicated in the content should not be construed as an express or implied promise, guarantee, or implication of Admiral Markets for any future performance. The value of the financial instrument may rise and fall, and the preservation of the asset's value is not guaranteed.
7. Leveraged products (including contracts for difference) are speculative in nature and may generate profit or loss. Before you start trading, make sure you fully understand the risks.